logo

Search projects

Examples: APPROACH

18 projects found

IM2PACT
f588a312-5f11-11eb-917b-acde48001122

Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain

Keywords: IMI projects Diabetes & metabolic disorders Neurodegenerative diseases Alzheimer's disease Tools for predicting/monitoring efficacy Drug delivery

IMPRiND
f0b066ae-5f11-11eb-917b-acde48001122

Inhibiting misfolded protein propagation in neurodegenerative diseases

Keywords: IMI projects Neurodegenerative diseases Alzheimer's disease Stem cells Target identification Drug discovery

MOPEAD
f3d7fdb0-5f11-11eb-917b-acde48001122

Models of patient engagement for Alzheimer’s disease

Keywords: IMI projects Neurodegenerative diseases Alzheimer's disease Patient involvement in R&D

NEURONET
f6bd053e-5f11-11eb-917b-acde48001122

Efficiently networking European neurodegeneration research

Keywords: IMI projects Neurodegenerative diseases Alzheimer's disease

PHAGO
f7b2e97c-5f11-11eb-917b-acde48001122

Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33

Keywords: IMI projects Neurodegenerative diseases Alzheimer's disease Stem cells Target identification Drug discovery

PRISM
f27f2c72-5f11-11eb-917b-acde48001122

Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD

Keywords: IMI projects Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Clinical trial design Disease taxonomy Target identification Drug discovery

PRISM 2
c8e5799e-c98a-11ed-a11d-ea435b63c148

Psychiatric ratings using intermediate stratified markers 2

Keywords: IMI projects Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Disease taxonomy Target identification

Pharma-Cog
f65ce9ec-5f11-11eb-917b-acde48001122

Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development

Keywords: IMI projects Neurodegenerative diseases Alzheimer's disease Tools for predicting/monitoring safety Clinical trial design Drug discovery